Selected research
Industry Growth & Trends
Global Plant Derivative Drug Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Plant Derivative Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Plant Derivative Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Plant Derivative Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Plant Derivative Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Plant Derivative Drug market include Yunnan Baiyao, Weleda, Tsumura, Tong Ren Tang, Tasly Holding Group, Taiji, Schwabe, Kwangdong and Jumpcan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Plant Derivative Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Plant Derivative Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Plant Derivative Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Plant Derivative Drug.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Plant Derivative Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Plant Derivative Drug Market by Company
Yunnan Baiyao
Weleda
Tsumura
Tong Ren Tang
Tasly Holding Group
Taiji
Schwabe
Kwangdong
Jumpcan Pharmaceutical
Huarun 999
GW Pharmaceuticals
Guangzhou Baiyunshan Pharmaceutical
China TCM
Buchang Pharmaceuticals
Bionorica Se
Plant Derivative Drug Segment by Type
Prescription Drug
OTC
Plant Derivative Drug Segment by Application
Tumor
Cardiovascular
Respiratory System
Other
Plant Derivative Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plant Derivative Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plant Derivative Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plant Derivative Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Plant Derivative Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Prescription Drug
- OTC
Applications
- Tumor
- Cardiovascular
- Respiratory System
- Other
Companies covered
- Yunnan Baiyao
- Weleda
- Tsumura
- Tong Ren Tang
- Tasly Holding Group
- Taiji
- Schwabe
- Kwangdong
- Jumpcan Pharmaceutical
- Huarun 999
- GW Pharmaceuticals
- Guangzhou Baiyunshan Pharmaceutical
- China TCM
- Buchang Pharmaceuticals
- Bionorica Se
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Plant Derivative Drug Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Plant Derivative Drug Market Size by Region (2021-2032)
- 1.4.1 Global Plant Derivative Drug Market Size by Region (2021-2026)
- 1.4.2 Global Plant Derivative Drug Market Size by Region (2027-2032)
- 1.5 Key Regions Plant Derivative Drug Market Size (2021-2032)
- 1.5.1 North America Plant Derivative Drug Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Plant Derivative Drug Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Plant Derivative Drug Market Size Growth Rate (2021-2032)
- 1.5.4 South America Plant Derivative Drug Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Plant Derivative Drug Market Size Growth Rate (2021-2032)
2 Plant Derivative Drug Market by Type
- 2.1 Type Introduction
- 2.1.1 Prescription Drug
- 2.1.2 OTC
- 2.2 Global Plant Derivative Drug Market Size by Type
- 2.2.1 Global Plant Derivative Drug Market Size Overview by Type (2021-2032)
- 2.2.2 Global Plant Derivative Drug Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Plant Derivative Drug Market Size Forecasted by Type (2027-2032)
- 2.3 Global Plant Derivative Drug Market Size by Regions
- 2.3.1 North America Plant Derivative Drug Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Plant Derivative Drug Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Plant Derivative Drug Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Plant Derivative Drug Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Plant Derivative Drug Market Size Breakdown by Type (2021-2026)
3 Plant Derivative Drug Market by Application
- 3.1 Type Introduction
- 3.1.1 Tumor
- 3.1.2 Cardiovascular
- 3.1.3 Respiratory System
- 3.1.4 Other
- 3.2 Global Plant Derivative Drug Market Size by Application
- 3.2.1 Global Plant Derivative Drug Market Size Overview by Application (2021-2032)
- 3.2.2 Global Plant Derivative Drug Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Plant Derivative Drug Market Size Forecasted by Application (2027-2032)
- 3.3 Global Plant Derivative Drug Market Size by Regions
- 3.3.1 North America Plant Derivative Drug Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Plant Derivative Drug Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Plant Derivative Drug Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Plant Derivative Drug Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Plant Derivative Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Plant Derivative Drug Industry Trends
- 4.2 Plant Derivative Drug Industry Drivers
- 4.3 Plant Derivative Drug Industry Opportunities and Challenges
- 4.4 Plant Derivative Drug Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Plant Derivative Drug Revenue (2021-2026)
- 5.2 Global Plant Derivative Drug Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Plant Derivative Drug Key Company Headquarters & Area Served
- 5.4 Global Plant Derivative Drug Company, Product Type & Application
- 5.5 Global Plant Derivative Drug Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Plant Derivative Drug Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Plant Derivative Drug Players Market Share by Revenue in 2025
- 5.6.3 2025 Plant Derivative Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Yunnan Baiyao
- 6.1.1 Yunnan Baiyao Company Information
- 6.1.2 Yunnan Baiyao Business Overview
- 6.1.3 Yunnan Baiyao Plant Derivative Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Yunnan Baiyao Plant Derivative Drug Product Portfolio
- 6.1.5 Yunnan Baiyao Recent Developments
- 6.2 Weleda
- 6.2.1 Weleda Company Information
- 6.2.2 Weleda Business Overview
- 6.2.3 Weleda Plant Derivative Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Weleda Plant Derivative Drug Product Portfolio
- 6.2.5 Weleda Recent Developments
- 6.3 Tsumura
- 6.3.1 Tsumura Company Information
- 6.3.2 Tsumura Business Overview
- 6.3.3 Tsumura Plant Derivative Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Tsumura Plant Derivative Drug Product Portfolio
- 6.3.5 Tsumura Recent Developments
- 6.4 Tong Ren Tang
- 6.4.1 Tong Ren Tang Company Information
- 6.4.2 Tong Ren Tang Business Overview
- 6.4.3 Tong Ren Tang Plant Derivative Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Tong Ren Tang Plant Derivative Drug Product Portfolio
- 6.4.5 Tong Ren Tang Recent Developments
- 6.5 Tasly Holding Group
- 6.5.1 Tasly Holding Group Company Information
- 6.5.2 Tasly Holding Group Business Overview
- 6.5.3 Tasly Holding Group Plant Derivative Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Tasly Holding Group Plant Derivative Drug Product Portfolio
- 6.5.5 Tasly Holding Group Recent Developments
- 6.6 Taiji
- 6.6.1 Taiji Company Information
- 6.6.2 Taiji Business Overview
- 6.6.3 Taiji Plant Derivative Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Taiji Plant Derivative Drug Product Portfolio
- 6.6.5 Taiji Recent Developments
- 6.7 Schwabe
- 6.7.1 Schwabe Company Information
- 6.7.2 Schwabe Business Overview
- 6.7.3 Schwabe Plant Derivative Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Schwabe Plant Derivative Drug Product Portfolio
- 6.7.5 Schwabe Recent Developments
- 6.8 Kwangdong
- 6.8.1 Kwangdong Company Information
- 6.8.2 Kwangdong Business Overview
- 6.8.3 Kwangdong Plant Derivative Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Kwangdong Plant Derivative Drug Product Portfolio
- 6.8.5 Kwangdong Recent Developments
- 6.9 Jumpcan Pharmaceutical
- 6.9.1 Jumpcan Pharmaceutical Company Information
- 6.9.2 Jumpcan Pharmaceutical Business Overview
- 6.9.3 Jumpcan Pharmaceutical Plant Derivative Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Jumpcan Pharmaceutical Plant Derivative Drug Product Portfolio
- 6.9.5 Jumpcan Pharmaceutical Recent Developments
- 6.10 Huarun 999
- 6.10.1 Huarun 999 Company Information
- 6.10.2 Huarun 999 Business Overview
- 6.10.3 Huarun 999 Plant Derivative Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Huarun 999 Plant Derivative Drug Product Portfolio
- 6.10.5 Huarun 999 Recent Developments
- 6.11 GW Pharmaceuticals
- 6.11.1 GW Pharmaceuticals Company Information
- 6.11.2 GW Pharmaceuticals Business Overview
- 6.11.3 GW Pharmaceuticals Plant Derivative Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 GW Pharmaceuticals Plant Derivative Drug Product Portfolio
- 6.11.5 GW Pharmaceuticals Recent Developments
- 6.12 Guangzhou Baiyunshan Pharmaceutical
- 6.12.1 Guangzhou Baiyunshan Pharmaceutical Company Information
- 6.12.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
- 6.12.3 Guangzhou Baiyunshan Pharmaceutical Plant Derivative Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Guangzhou Baiyunshan Pharmaceutical Plant Derivative Drug Product Portfolio
- 6.12.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
- 6.13 China TCM
- 6.13.1 China TCM Company Information
- 6.13.2 China TCM Business Overview
- 6.13.3 China TCM Plant Derivative Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 China TCM Plant Derivative Drug Product Portfolio
- 6.13.5 China TCM Recent Developments
- 6.14 Buchang Pharmaceuticals
- 6.14.1 Buchang Pharmaceuticals Company Information
- 6.14.2 Buchang Pharmaceuticals Business Overview
- 6.14.3 Buchang Pharmaceuticals Plant Derivative Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Buchang Pharmaceuticals Plant Derivative Drug Product Portfolio
- 6.14.5 Buchang Pharmaceuticals Recent Developments
- 6.15 Bionorica Se
- 6.15.1 Bionorica Se Company Information
- 6.15.2 Bionorica Se Business Overview
- 6.15.3 Bionorica Se Plant Derivative Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Bionorica Se Plant Derivative Drug Product Portfolio
- 6.15.5 Bionorica Se Recent Developments
7 North America
- 7.1 North America Plant Derivative Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Plant Derivative Drug Market Size by Country (2021-2026)
- 7.3 North America Plant Derivative Drug Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Plant Derivative Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Plant Derivative Drug Market Size by Country (2021-2026)
- 8.3 Europe Plant Derivative Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Plant Derivative Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Plant Derivative Drug Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Plant Derivative Drug Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Plant Derivative Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Plant Derivative Drug Market Size by Country (2021-2026)
- 10.3 South America Plant Derivative Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Plant Derivative Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Plant Derivative Drug Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Plant Derivative Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst